tm logo
BACFENSSI
Live/Registered
REGISTERED

on 30 Aug 2022

Last Applicant/ Owned by

18 Hasivim street

Petach Tikva

IL

Serial Number

79320158 filed on 08th Jul 2021

Registration Number

6829818 registered on 30th Aug 2022

in the Principal Register

Correspondent Address

Bharati Bakshani

Ladas & Parry, LLP

1040 Avenue of the Americas

New York, NY 10018

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

BACFENSSI

Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all coated with polymer-lipid matrix for sustained drug delivery; Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staplRead More

Classification Information


Class [010]
Medical Instrument Products


Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all coated with polymer-lipid matrix for sustained drug delivery; Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all impregnated with polymer-lipid matrix for sustained antibiotic drug delivery; Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all coated with polymer-lipid matrix for sustained antibiotic drug delivery

Class [005]
Pharmaceutical Products


Drug carriers for medical use, namely, polymer-lipid matrix formulation for localized drug delivery; drug delivery formulations for medical use, namely, drug delivery agents in the form of polymer-lipid matrix for sustained drug delivery; drug delivery formulations for medical use, namely, drug delivery formulations being drug delivery agents in the form of powders and pastes that provide sustained release of the active ingredients for a wide variety of pharmaceuticals; antibiotic delivery systems comprising polymer-lipid based matrix formulation for the continuous release of antibiotic drugs for medical use, namely for the prevention and treatment of infections associated with surgical procedures; drug delivery systems for medical use, namely, drug delivery agents being polymeric based particles coated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being polymeric based particles impregnated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being mineral based particles coated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being mineral based particles impregnated with polymer-lipid matrix for sustained antibiotic drug delivery

Mark Details


Serial Number

No 79320158

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2T22756324

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Jan 2023FINAL DECISION TRANSACTION PROCESSED BY IB
09th Dec 2022FINAL DISPOSITION PROCESSED
09th Dec 2022FINAL DISPOSITION NOTICE SENT TO IB
30th Nov 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30th Aug 2022REGISTERED-PRINCIPAL REGISTER
30th Aug 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
14th Jun 2022PUBLISHED FOR OPPOSITION
14th Jun 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25th May 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th May 2022EXAMINERS AMENDMENT -WRITTEN